img

Global siRNA Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global siRNA Drug Market Insights, Forecast to 2034

The global research and development of siRNA drugs is still in the development stage of the industry. There are about 300 projects after the global laboratory stage, and the overall development trend is good. Its therapeutic areas are mainly concentrated in tumor, neurology and ophthalmology. Since siRNA has a larger molecular weight and stronger charge than ASO, it is more difficult for siRNA to enter cells by itself, so siRNA drugs have higher requirements for carriers, which is why siRNA drugs are approved later than ASO drugs big reason.
Global siRNA Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, siRNA Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global siRNA Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global siRNA Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Genzyme
Alnylam
Dicerna
Quark Pharmaceuticals
Arrowhead
Exicure
Miragen Therapeutics
Silence
Sylentis
Avidity Biosciences
Dicerna
BioNTech
Moderna Therapeutics
The WhiteOak Group, Inc.
Segment by Type
Givlaari
Patisiran
Givosiran

Segment by Application


Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ siRNA Drug plant distribution, commercial date of siRNA Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, siRNA Drug introduction, etc. siRNA Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of siRNA Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 siRNA Drug Product Introduction
1.2 Market by Type
1.2.1 Global siRNA Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Givlaari
1.2.3 Patisiran
1.2.4 Givosiran
1.3 Market by Application
1.3.1 Global siRNA Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Single Gene Rare Disease
1.3.3 Protein Deposition Disease
1.3.4 Chronic Liver Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global siRNA Drug Sales Estimates and Forecasts 2018-2029
2.2 Global siRNA Drug Revenue by Region
2.2.1 Global siRNA Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global siRNA Drug Revenue by Region (2018-2024)
2.2.3 Global siRNA Drug Revenue by Region (2024-2029)
2.2.4 Global siRNA Drug Revenue Market Share by Region (2018-2029)
2.3 Global siRNA Drug Sales Estimates and Forecasts 2018-2029
2.4 Global siRNA Drug Sales by Region
2.4.1 Global siRNA Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global siRNA Drug Sales by Region (2018-2024)
2.4.3 Global siRNA Drug Sales by Region (2024-2029)
2.4.4 Global siRNA Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global siRNA Drug Sales by Manufacturers
3.1.1 Global siRNA Drug Sales by Manufacturers (2018-2024)
3.1.2 Global siRNA Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of siRNA Drug in 2022
3.2 Global siRNA Drug Revenue by Manufacturers
3.2.1 Global siRNA Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global siRNA Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by siRNA Drug Revenue in 2022
3.3 Global Key Players of siRNA Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global siRNA Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global siRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of siRNA Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of siRNA Drug, Product Offered and Application
3.8 Global Key Manufacturers of siRNA Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global siRNA Drug Sales by Type
4.1.1 Global siRNA Drug Historical Sales by Type (2018-2024)
4.1.2 Global siRNA Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global siRNA Drug Sales Market Share by Type (2018-2029)
4.2 Global siRNA Drug Revenue by Type
4.2.1 Global siRNA Drug Historical Revenue by Type (2018-2024)
4.2.2 Global siRNA Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global siRNA Drug Revenue Market Share by Type (2018-2029)
4.3 Global siRNA Drug Price by Type
4.3.1 Global siRNA Drug Price by Type (2018-2024)
4.3.2 Global siRNA Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global siRNA Drug Sales by Application
5.1.1 Global siRNA Drug Historical Sales by Application (2018-2024)
5.1.2 Global siRNA Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global siRNA Drug Sales Market Share by Application (2018-2029)
5.2 Global siRNA Drug Revenue by Application
5.2.1 Global siRNA Drug Historical Revenue by Application (2018-2024)
5.2.2 Global siRNA Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global siRNA Drug Revenue Market Share by Application (2018-2029)
5.3 Global siRNA Drug Price by Application
5.3.1 Global siRNA Drug Price by Application (2018-2024)
5.3.2 Global siRNA Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada siRNA Drug Market Size by Type
6.1.1 US & Canada siRNA Drug Sales by Type (2018-2029)
6.1.2 US & Canada siRNA Drug Revenue by Type (2018-2029)
6.2 US & Canada siRNA Drug Market Size by Application
6.2.1 US & Canada siRNA Drug Sales by Application (2018-2029)
6.2.2 US & Canada siRNA Drug Revenue by Application (2018-2029)
6.3 US & Canada siRNA Drug Market Size by Country
6.3.1 US & Canada siRNA Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada siRNA Drug Sales by Country (2018-2029)
6.3.3 US & Canada siRNA Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe siRNA Drug Market Size by Type
7.1.1 Europe siRNA Drug Sales by Type (2018-2029)
7.1.2 Europe siRNA Drug Revenue by Type (2018-2029)
7.2 Europe siRNA Drug Market Size by Application
7.2.1 Europe siRNA Drug Sales by Application (2018-2029)
7.2.2 Europe siRNA Drug Revenue by Application (2018-2029)
7.3 Europe siRNA Drug Market Size by Country
7.3.1 Europe siRNA Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe siRNA Drug Sales by Country (2018-2029)
7.3.3 Europe siRNA Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China siRNA Drug Market Size
8.1.1 China siRNA Drug Sales (2018-2029)
8.1.2 China siRNA Drug Revenue (2018-2029)
8.2 China siRNA Drug Market Size by Application
8.2.1 China siRNA Drug Sales by Application (2018-2029)
8.2.2 China siRNA Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia siRNA Drug Market Size by Type
9.1.1 Asia siRNA Drug Sales by Type (2018-2029)
9.1.2 Asia siRNA Drug Revenue by Type (2018-2029)
9.2 Asia siRNA Drug Market Size by Application
9.2.1 Asia siRNA Drug Sales by Application (2018-2029)
9.2.2 Asia siRNA Drug Revenue by Application (2018-2029)
9.3 Asia siRNA Drug Sales by Region
9.3.1 Asia siRNA Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia siRNA Drug Revenue by Region (2018-2029)
9.3.3 Asia siRNA Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America siRNA Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America siRNA Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America siRNA Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America siRNA Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America siRNA Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America siRNA Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America siRNA Drug Sales by Country
10.3.1 Middle East, Africa and Latin America siRNA Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America siRNA Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America siRNA Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Genzyme
11.1.1 Genzyme Company Information
11.1.2 Genzyme Overview
11.1.3 Genzyme siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Genzyme siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Genzyme Recent Developments
11.2 Alnylam
11.2.1 Alnylam Company Information
11.2.2 Alnylam Overview
11.2.3 Alnylam siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Alnylam siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alnylam Recent Developments
11.3 Dicerna
11.3.1 Dicerna Company Information
11.3.2 Dicerna Overview
11.3.3 Dicerna siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Dicerna siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dicerna Recent Developments
11.4 Quark Pharmaceuticals
11.4.1 Quark Pharmaceuticals Company Information
11.4.2 Quark Pharmaceuticals Overview
11.4.3 Quark Pharmaceuticals siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Quark Pharmaceuticals siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Quark Pharmaceuticals Recent Developments
11.5 Arrowhead
11.5.1 Arrowhead Company Information
11.5.2 Arrowhead Overview
11.5.3 Arrowhead siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Arrowhead siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Arrowhead Recent Developments
11.6 Exicure
11.6.1 Exicure Company Information
11.6.2 Exicure Overview
11.6.3 Exicure siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Exicure siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Exicure Recent Developments
11.7 Miragen Therapeutics
11.7.1 Miragen Therapeutics Company Information
11.7.2 Miragen Therapeutics Overview
11.7.3 Miragen Therapeutics siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Miragen Therapeutics siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Miragen Therapeutics Recent Developments
11.8 Silence
11.8.1 Silence Company Information
11.8.2 Silence Overview
11.8.3 Silence siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Silence siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Silence Recent Developments
11.9 Sylentis
11.9.1 Sylentis Company Information
11.9.2 Sylentis Overview
11.9.3 Sylentis siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sylentis siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sylentis Recent Developments
11.10 Avidity Biosciences
11.10.1 Avidity Biosciences Company Information
11.10.2 Avidity Biosciences Overview
11.10.3 Avidity Biosciences siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Avidity Biosciences siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Avidity Biosciences Recent Developments
11.11 Dicerna
11.11.1 Dicerna Company Information
11.11.2 Dicerna Overview
11.11.3 Dicerna siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Dicerna siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dicerna Recent Developments
11.12 BioNTech
11.12.1 BioNTech Company Information
11.12.2 BioNTech Overview
11.12.3 BioNTech siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 BioNTech siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BioNTech Recent Developments
11.13 Moderna Therapeutics
11.13.1 Moderna Therapeutics Company Information
11.13.2 Moderna Therapeutics Overview
11.13.3 Moderna Therapeutics siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Moderna Therapeutics siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Moderna Therapeutics Recent Developments
11.14 The WhiteOak Group, Inc.
11.14.1 The WhiteOak Group, Inc. Company Information
11.14.2 The WhiteOak Group, Inc. Overview
11.14.3 The WhiteOak Group, Inc. siRNA Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 The WhiteOak Group, Inc. siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 The WhiteOak Group, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 siRNA Drug Industry Chain Analysis
12.2 siRNA Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 siRNA Drug Production Mode & Process
12.4 siRNA Drug Sales and Marketing
12.4.1 siRNA Drug Sales Channels
12.4.2 siRNA Drug Distributors
12.5 siRNA Drug Customers
13 Market Dynamics
13.1 siRNA Drug Industry Trends
13.2 siRNA Drug Market Drivers
13.3 siRNA Drug Market Challenges
13.4 siRNA Drug Market Restraints
14 Key Findings in The Global siRNA Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global siRNA Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Givlaari
Table 3. Major Manufacturers of Patisiran
Table 4. Major Manufacturers of Givosiran
Table 5. Global siRNA Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global siRNA Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global siRNA Drug Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global siRNA Drug Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global siRNA Drug Revenue Market Share by Region (2018-2024)
Table 10. Global siRNA Drug Revenue Market Share by Region (2024-2029)
Table 11. Global siRNA Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global siRNA Drug Sales by Region (2018-2024) & (K Units)
Table 13. Global siRNA Drug Sales by Region (2024-2029) & (K Units)
Table 14. Global siRNA Drug Sales Market Share by Region (2018-2024)
Table 15. Global siRNA Drug Sales Market Share by Region (2024-2029)
Table 16. Global siRNA Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global siRNA Drug Sales Share by Manufacturers (2018-2024)
Table 18. Global siRNA Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global siRNA Drug Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of siRNA Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. siRNA Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global siRNA Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global siRNA Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drug as of 2022)
Table 24. Global Key Manufacturers of siRNA Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of siRNA Drug, Product Offered and Application
Table 26. Global Key Manufacturers of siRNA Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global siRNA Drug Sales by Type (2018-2024) & (K Units)
Table 29. Global siRNA Drug Sales by Type (2024-2029) & (K Units)
Table 30. Global siRNA Drug Sales Share by Type (2018-2024)
Table 31. Global siRNA Drug Sales Share by Type (2024-2029)
Table 32. Global siRNA Drug Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global siRNA Drug Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global siRNA Drug Revenue Share by Type (2018-2024)
Table 35. Global siRNA Drug Revenue Share by Type (2024-2029)
Table 36. siRNA Drug Price by Type (2018-2024) & (US$/Unit)
Table 37. Global siRNA Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global siRNA Drug Sales by Application (2018-2024) & (K Units)
Table 39. Global siRNA Drug Sales by Application (2024-2029) & (K Units)
Table 40. Global siRNA Drug Sales Share by Application (2018-2024)
Table 41. Global siRNA Drug Sales Share by Application (2024-2029)
Table 42. Global siRNA Drug Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global siRNA Drug Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global siRNA Drug Revenue Share by Application (2018-2024)
Table 45. Global siRNA Drug Revenue Share by Application (2024-2029)
Table 46. siRNA Drug Price by Application (2018-2024) & (US$/Unit)
Table 47. Global siRNA Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada siRNA Drug Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada siRNA Drug Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada siRNA Drug Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada siRNA Drug Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada siRNA Drug Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada siRNA Drug Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada siRNA Drug Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada siRNA Drug Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada siRNA Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada siRNA Drug Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada siRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada siRNA Drug Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 61. Europe siRNA Drug Sales by Type (2018-2024) & (K Units)
Table 62. Europe siRNA Drug Sales by Type (2024-2029) & (K Units)
Table 63. Europe siRNA Drug Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe siRNA Drug Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe siRNA Drug Sales by Application (2018-2024) & (K Units)
Table 66. Europe siRNA Drug Sales by Application (2024-2029) & (K Units)
Table 67. Europe siRNA Drug Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe siRNA Drug Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe siRNA Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe siRNA Drug Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe siRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe siRNA Drug Sales by Country (2018-2024) & (K Units)
Table 73. Europe siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 74. China siRNA Drug Sales by Type (2018-2024) & (K Units)
Table 75. China siRNA Drug Sales by Type (2024-2029) & (K Units)
Table 76. China siRNA Drug Revenue by Type (2018-2024) & (US$ Million)
Table 77. China siRNA Drug Revenue by Type (2024-2029) & (US$ Million)
Table 78. China siRNA Drug Sales by Application (2018-2024) & (K Units)
Table 79. China siRNA Drug Sales by Application (2024-2029) & (K Units)
Table 80. China siRNA Drug Revenue by Application (2018-2024) & (US$ Million)
Table 81. China siRNA Drug Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia siRNA Drug Sales by Type (2018-2024) & (K Units)
Table 83. Asia siRNA Drug Sales by Type (2024-2029) & (K Units)
Table 84. Asia siRNA Drug Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia siRNA Drug Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia siRNA Drug Sales by Application (2018-2024) & (K Units)
Table 87. Asia siRNA Drug Sales by Application (2024-2029) & (K Units)
Table 88. Asia siRNA Drug Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia siRNA Drug Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia siRNA Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia siRNA Drug Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia siRNA Drug Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia siRNA Drug Sales by Region (2018-2024) & (K Units)
Table 94. Asia siRNA Drug Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America siRNA Drug Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America siRNA Drug Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America siRNA Drug Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America siRNA Drug Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America siRNA Drug Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America siRNA Drug Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America siRNA Drug Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America siRNA Drug Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America siRNA Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America siRNA Drug Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America siRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America siRNA Drug Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 108. Genzyme Company Information
Table 109. Genzyme Description and Major Businesses
Table 110. Genzyme siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Genzyme siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Genzyme Recent Developments
Table 113. Alnylam Company Information
Table 114. Alnylam Description and Major Businesses
Table 115. Alnylam siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Alnylam siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Alnylam Recent Developments
Table 118. Dicerna Company Information
Table 119. Dicerna Description and Major Businesses
Table 120. Dicerna siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Dicerna siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Dicerna Recent Developments
Table 123. Quark Pharmaceuticals Company Information
Table 124. Quark Pharmaceuticals Description and Major Businesses
Table 125. Quark Pharmaceuticals siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Quark Pharmaceuticals siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Quark Pharmaceuticals Recent Developments
Table 128. Arrowhead Company Information
Table 129. Arrowhead Description and Major Businesses
Table 130. Arrowhead siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Arrowhead siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Arrowhead Recent Developments
Table 133. Exicure Company Information
Table 134. Exicure Description and Major Businesses
Table 135. Exicure siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Exicure siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Exicure Recent Developments
Table 138. Miragen Therapeutics Company Information
Table 139. Miragen Therapeutics Description and Major Businesses
Table 140. Miragen Therapeutics siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Miragen Therapeutics siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Miragen Therapeutics Recent Developments
Table 143. Silence Company Information
Table 144. Silence Description and Major Businesses
Table 145. Silence siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Silence siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Silence Recent Developments
Table 148. Sylentis Company Information
Table 149. Sylentis Description and Major Businesses
Table 150. Sylentis siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Sylentis siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Sylentis Recent Developments
Table 153. Avidity Biosciences Company Information
Table 154. Avidity Biosciences Description and Major Businesses
Table 155. Avidity Biosciences siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Avidity Biosciences siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Avidity Biosciences Recent Developments
Table 158. Dicerna Company Information
Table 159. Dicerna Description and Major Businesses
Table 160. Dicerna siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Dicerna siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Dicerna Recent Developments
Table 163. BioNTech Company Information
Table 164. BioNTech Description and Major Businesses
Table 165. BioNTech siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. BioNTech siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. BioNTech Recent Developments
Table 168. Moderna Therapeutics Company Information
Table 169. Moderna Therapeutics Description and Major Businesses
Table 170. Moderna Therapeutics siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Moderna Therapeutics siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Moderna Therapeutics Recent Developments
Table 173. The WhiteOak Group, Inc. Company Information
Table 174. The WhiteOak Group, Inc. Description and Major Businesses
Table 175. The WhiteOak Group, Inc. siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. The WhiteOak Group, Inc. siRNA Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. The WhiteOak Group, Inc. Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. siRNA Drug Distributors List
Table 181. siRNA Drug Customers List
Table 182. siRNA Drug Market Trends
Table 183. siRNA Drug Market Drivers
Table 184. siRNA Drug Market Challenges
Table 185. siRNA Drug Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. siRNA Drug Product Picture
Figure 2. Global siRNA Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global siRNA Drug Market Share by Type in 2022 & 2029
Figure 4. Givlaari Product Picture
Figure 5. Patisiran Product Picture
Figure 6. Givosiran Product Picture
Figure 7. Global siRNA Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global siRNA Drug Market Share by Application in 2022 & 2029
Figure 9. Single Gene Rare Disease
Figure 10. Protein Deposition Disease
Figure 11. Chronic Liver Disease
Figure 12. Others
Figure 13. siRNA Drug Report Years Considered
Figure 14. Global siRNA Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global siRNA Drug Revenue 2018-2029 (US$ Million)
Figure 16. Global siRNA Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global siRNA Drug Revenue Market Share by Region (2018-2029)
Figure 18. Global siRNA Drug Sales 2018-2029 ((K Units)
Figure 19. Global siRNA Drug Sales Market Share by Region (2018-2029)
Figure 20. US & Canada siRNA Drug Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada siRNA Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe siRNA Drug Sales YoY (2018-2029) & (K Units)
Figure 23. Europe siRNA Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China siRNA Drug Sales YoY (2018-2029) & (K Units)
Figure 25. China siRNA Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) siRNA Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) siRNA Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America siRNA Drug Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America siRNA Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The siRNA Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of siRNA Drug in the World: Market Share by siRNA Drug Revenue in 2022
Figure 32. Global siRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global siRNA Drug Sales Market Share by Type (2018-2029)
Figure 34. Global siRNA Drug Revenue Market Share by Type (2018-2029)
Figure 35. Global siRNA Drug Sales Market Share by Application (2018-2029)
Figure 36. Global siRNA Drug Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada siRNA Drug Sales Market Share by Type (2018-2029)
Figure 38. US & Canada siRNA Drug Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada siRNA Drug Sales Market Share by Application (2018-2029)
Figure 40. US & Canada siRNA Drug Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada siRNA Drug Revenue Share by Country (2018-2029)
Figure 42. US & Canada siRNA Drug Sales Share by Country (2018-2029)
Figure 43. U.S. siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Canada siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 45. Europe siRNA Drug Sales Market Share by Type (2018-2029)
Figure 46. Europe siRNA Drug Revenue Market Share by Type (2018-2029)
Figure 47. Europe siRNA Drug Sales Market Share by Application (2018-2029)
Figure 48. Europe siRNA Drug Revenue Market Share by Application (2018-2029)
Figure 49. Europe siRNA Drug Revenue Share by Country (2018-2029)
Figure 50. Europe siRNA Drug Sales Share by Country (2018-2029)
Figure 51. Germany siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 52. France siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Italy siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 55. Russia siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 56. China siRNA Drug Sales Market Share by Type (2018-2029)
Figure 57. China siRNA Drug Revenue Market Share by Type (2018-2029)
Figure 58. China siRNA Drug Sales Market Share by Application (2018-2029)
Figure 59. China siRNA Drug Revenue Market Share by Application (2018-2029)
Figure 60. Asia siRNA Drug Sales Market Share by Type (2018-2029)
Figure 61. Asia siRNA Drug Revenue Market Share by Type (2018-2029)
Figure 62. Asia siRNA Drug Sales Market Share by Application (2018-2029)
Figure 63. Asia siRNA Drug Revenue Market Share by Application (2018-2029)
Figure 64. Asia siRNA Drug Revenue Share by Region (2018-2029)
Figure 65. Asia siRNA Drug Sales Share by Region (2018-2029)
Figure 66. Japan siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 70. India siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America siRNA Drug Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America siRNA Drug Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America siRNA Drug Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America siRNA Drug Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America siRNA Drug Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America siRNA Drug Sales Share by Country (2018-2029)
Figure 77. Brazil siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Israel siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries siRNA Drug Revenue (2018-2029) & (US$ Million)
Figure 82. siRNA Drug Value Chain
Figure 83. siRNA Drug Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries